MétaCan
Menu
Back to cohort
Record W2759878426 · doi:10.2196/iproc.8427

Impact of AllazoEngine-Targeted Interventions on Medication Adherence: Repeated Measures Difference-in-Differences Analysis

2017· article· en· W2759878426 on OpenAlexvenueno aff
Brittanie Gracey, Patricia Prince, Clifford B. Jones, S. O’ Connor, Estay Greene

Bibliographic record

VenueIproceedings · 2017
Typearticle
Languageen
FieldMedicine
TopicMedication Adherence and Compliance
Canadian institutionsnot available
Fundersnot available
KeywordsIntervention (counseling)DemographicsPsychological interventionMedication adherenceMedicinePredictive analyticsAnalyticsData scienceComputer scienceNursingInternal medicine

Abstract

fetched live from OpenAlex

Background: AllazoHealth utilizes predictive analytics to improve medication adherence by targeting patients whose behavior can be changed with intervention programs. The AllazoEngine utilizes Rx claims, previous intervention data, and demographics to predict future adherence, to prioritize the patients whose behaviors can be changed, and to select the intervention channel and messaging most effective for each individual patient. Blue Cross and Blue Shield of North Carolina commissioned AllazoHealth’s predictive analytics and separately commissioned medication intervention delivery services for this adherence program. Objective: This study aimed to evaluate the effectiveness of the AllazoEngine and targeted interventions to improve medication adherence. Methods: This was a double-blind, randomized controlled trial (RCT) focused on RAS antagonists, oral anti-diabetics, and Statins. Patients were randomized to receive no intervention, traditional non-Allazo-targeted interventions, or interventions targeted by the AllazoEngine. All interventions consisted of live calls, direct mail to patients, and faxes to prescribers. Patients were defined as adherent in accordance with Medicare Star ratings methodology if their proportion of days covered (PDC) was greater than 80%. Patients’ adherence status in 2015 was compared to their adherence status in 2016 after the intervention period. Difference-in-Differences (DiD) analysis was used to compare the effect of each intervention method. Statistical significance was set to 10%. Results: The primary study population consisted of 14,377 controls, 5,423 traditional non-Allazo targeted-intervention patients and 24,527 Allazo targeted intervention patients. Patients had comparable characteristics at baseline and comparable decrease in medication adherence in the pre-intervention observation period across the intervention groups. Non-Allazo-targeted interventions did not statistically improve the likelihood of adherence. Patients who received Allazo-targeted interventions performed statistically better than both the non-Allazo targeted group and control group (P=.06 and .03). Assuming net positive uplift from non-Allazo interventions, Allazo interventions accounted for 7.7 times the per-patient uplift in adherence compared to non-Allazo interventions. Conclusions: Due to the specific study design of not including new patients, adherence decreased in each intervention group over the intervention period. However, the decrease was significantly less for those in the Allazo group compared to both the non-Allazo and control groups.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.014
metaresearch head score (Gemma)0.015
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.014
Threshold uncertainty score0.075

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0140.015
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0030.004
Bibliometrics0.0010.001
Science and technology studies0.0000.001
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.111
GPT teacher head0.404
Teacher spread0.293 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2017
Admission routes1
Has abstractyes

Explore more

Same venueIproceedingsSame topicMedication Adherence and ComplianceFrench-language works237,207